These modifications and approaches generated Pelizaeus-Merzbacher Disease (PMD)-specific human iPSCs from two individuals with varying clinical severity and PLP1 missense mutations. The gene discussed is PLP1; the disease is Pelizeaus-Merzbacher spectrum disorder.